ALNYLAM PHARMACEUTICALS, INC. (ALNY) FY2026 YTD Q2 Statement of Cash Flows
2026-01-01 to 2026-06-30
Statement of Cash Flows
2026-01-01 to 2026-06-30
Swipe to see the full flow
Chart details
ALNYLAM PHARMACEUTICALS, INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026
Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Dec 31, 2025
- 1,658,807,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- 397,228,000 US dollars. Net cash provided.
- Net income (loss)
- 370,485,000 US dollars
- Depreciation and amortization
- 27,452,000 US dollars
- Non-cash interest expense on liabilities related to the sale of future royalties and development funding
- 145,279,000 US dollars
- Stock-based compensation expense
- 156,779,000 US dollars
- Realized and unrealized loss on marketable equity securities
- 0 US dollars
- Deferred income taxes
- 11,967,000 US dollars
- Other
- 11,272,000 US dollars
- Accounts receivable, net
- negative 142,023,000 US dollars
- Inventory
- negative 3,044,000 US dollars
- Prepaid expenses and other assets
- negative 65,692,000 US dollars
- Accounts payable, accrued expenses and other liabilities
- negative 114,416,000 US dollars
- Deferred revenue
- negative 831,000 US dollars
- Investing activities
- negative 388,999,000 US dollars. Net cash used.
- Purchases of property, plant and equipment
- negative 56,513,000 US dollars
- Purchases of marketable securities
- negative 837,297,000 US dollars
- Sales and maturities of marketable securities
- 485,986,000 US dollars
- Proceeds from maturity of restricted and other investments
- 66,725,000 US dollars
- Purchases of restricted and other investments
- negative 22,000,000 US dollars
- Other investing activities
- negative 25,900,000 US dollars
- Financing activities
- 51,951,000 US dollars. Net cash provided.
- Proceeds from exercise of stock options and other types of equity, net
- 46,718,000 US dollars
- Proceeds from liabilities related to the sale of future royalties and development funding
- 12,000,000 US dollars
- Repayment of liabilities related to the sale of future royalties and development funding
- negative 6,752,000 US dollars
- Other financing activities
- negative 15,000 US dollars
- Operating adjustment reconciliation
- 352,749,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 58,718,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 941,710,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- negative 9,509,000 US dollars
- Ending cash on Jun 30, 2026
- 1,709,478,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 2,107,986,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- 50,671,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- 1.07×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- Operating cash flow
- 397,228,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 56,513,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- 340,715,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $26.74M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 397,228,000 US dollars minus 56,513,000 US dollars equals 340,715,000 US dollars.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!